Catalyst Wire Dossier Catalyst Wire Dossier

Nalbuphine Extended-Release Tablets

nalbuphine · Trevi Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nalbuphine Extended-Release Tablets, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants [Phase 1]

See pricing